Author

K. J. Park

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:bacteria (other)· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. Jimenez-Sanchez· 1 shared A. Snyder· 1 shared A. Vargas· 1 shared B. Weigelt· 1 shared B. Y. Park· 1 shared C. Zhang· 1 shared D. A. Schwartz· 1 shared D. Jung· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Jimenez-Sanchez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Bacterium secretes chemical inhibitor that sensitizes competitor to bacteriophage infection

Z. Zang, C. Zhang, K. J. Park, D. A. Schwartz, R. Podicheti, J. T. Lennon, J. P. Gerdt

The paper identifies a bacterial secondary metabolite that sensitizes competitors to phage infection, providing a fitness advantage to the producer.

bioRxiv · Jan 31, 2024Microbiology

E prostanoid receptor 4 expressing macrophages promote the regeneration of the intestinal epithelial barrier upon inflammation

Y. R. Na, D. Jung, M. Stakenborg, G. J. Gu, M. R. Jeong, H. R. Jang, S. Y. Suh, H. J. Kim, Y. H. Kwon, T. S. Sung, S. B. Ryoo, K. J. Park, J. P. Im, J. Y. Park, Y. S. Lee, , S. H. Seok

The paper identifies EP4-expressing intestinal macrophages that promote mucosal healing by secreting CXCL1 during inflammation resolution.

bioRxiv · May 4, 2020Immunology

Unraveling Tumor-Immune Heterogeneity in Advanced Ovarian Cancer Uncovers Immunogenic Effect of Chemotherapy

A. Jimenez-Sanchez, P. Cybulska, K. Lavigne, T. Walther, I. Nikolovski, Y. Mazaheri, B. Weigelt, D. S. Chi, K. J. Park, T. Hollmann, D.-L. Couturier, A. Vargas, J. D. Brenton, E. Sala, A. Snyder, M. L. Miller

This study analyzes tumor-immune heterogeneity in ovarian cancer before and after chemotherapy, finding that chemotherapy increases cytotoxic immune activation in site-matched samples.

bioRxiv · Oct 17, 2018Cancer Biology